Health Savings News talks with Shabbir Safdar, the Executive Director of the Partnership for Safe Medicines, about the risks patients face when they leave the supply chain for medication in an effort to access affordable treatment.
Shabbir Imber Safdar has been at the Partnership for Safe Medicines for over a decade and was tapped to lead it in 2017.
The Partnership, founded in 2003, is a not for profit focused entirely on researching the danger of counterfeit drugs in America and educating the public about how to stay safe from them.
Shabbir is passionate about patient safety and the dangers of counterfeits, having seen them firsthand the dangers of counterfeits in countries around the world where a closed, secure drug supply chain doesn’t exist.
Listen to Episode 20: Counterfeit Medications (featuring Partnership for Safe Medicines)
Tags: Adulterated Counterfeit Drug Importation Education NADDI Member Online Pharmacy Patient Harm Podcast Supply Chain